Skip to main content
Erschienen in: Supportive Care in Cancer 2/2018

01.09.2017 | Original Article

Guidance for establishing an integrative oncology service in the Australian healthcare setting—a discussion paper

verfasst von: Suzanne J. Grant, Jennifer Hunter, Alan Bensoussan, Geoff P. Delaney

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

There is an obvious mismatch between the high reported rates of use of traditional and complementary medicines (T&CM) by Australian cancer patients and cancer survivors and the low numbers of Australian cancer services integrating T&CM. An estimated 65% of Australian cancer patients use at least one form of T&CM. Over half use T&CM in conjunction with conventional cancer therapy. Yet, less than 20% of Australian hospital cancer care facilities provide access to T&CM. This compares to around 70% of UK cancer care facilities offering at least one T&CM therapy. Barriers to developing integrative oncology services include determining an appropriate service model and revenue structure; concerns with ethical and legal issues such as regulations and credentialing; and inadequate high-quality scientific evidence demonstrating safety and effectiveness, including concerns about the possibility of adversely affecting chemotherapy or radiotherapy treatment. This paper aims to provide general guidance and practical strategies for those seeking to develop integrative oncology services in Australian cancer care facilities.
Literatur
1.
Zurück zum Zitat Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D et al (2010) The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific J Clin Oncol 6(4):342–349CrossRef Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D et al (2010) The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific J Clin Oncol 6(4):342–349CrossRef
2.
Zurück zum Zitat Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203 Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203
3.
Zurück zum Zitat Parliament of Australia Senate Community Affairs References Committee (2005) The cancer journey: informing choice. Commonwealth of Australia, Canberra Parliament of Australia Senate Community Affairs References Committee (2005) The cancer journey: informing choice. Commonwealth of Australia, Canberra
4.
Zurück zum Zitat Bell R (2010) A review of complementary and alternative medicine practices among cancer survivors. Clin J Oncol Nurs 14(3):365–370CrossRefPubMed Bell R (2010) A review of complementary and alternative medicine practices among cancer survivors. Clin J Oncol Nurs 14(3):365–370CrossRefPubMed
5.
Zurück zum Zitat Amichai T, Grossman M, Richard M (2012) Lung cancer patients’ beliefs about complementary and alternative medicine in the promotion of their wellness. Eur J Oncol Nurs 15(5):520–527CrossRef Amichai T, Grossman M, Richard M (2012) Lung cancer patients’ beliefs about complementary and alternative medicine in the promotion of their wellness. Eur J Oncol Nurs 15(5):520–527CrossRef
6.
Zurück zum Zitat King T, Grant S, Taylor S, Houteas K, Barnett C, White K (2015) A CAM do approach: the attitudes, use and disclosure of the use of complementary and alternative medicine (CAM) in those with myeloma. Clin Lymphoma Myeloma and Leuk 15:e317–e3e8CrossRef King T, Grant S, Taylor S, Houteas K, Barnett C, White K (2015) A CAM do approach: the attitudes, use and disclosure of the use of complementary and alternative medicine (CAM) in those with myeloma. Clin Lymphoma Myeloma and Leuk 15:e317–e3e8CrossRef
7.
Zurück zum Zitat Beatty L, Koczwara B, Knott V, Wade T (2011) Why people chose to not use complementary therapies during cancer treatment: a focus group. Euro J Cancer Care 21(1):98–106CrossRef Beatty L, Koczwara B, Knott V, Wade T (2011) Why people chose to not use complementary therapies during cancer treatment: a focus group. Euro J Cancer Care 21(1):98–106CrossRef
8.
Zurück zum Zitat Raszeja V, Jordens C, Kerridge I (2013) Survey of practices and polices relating to the use of complementary and alternatives medicines and therapies in New South Wales cancer services. Intern Med J 43:84–88CrossRefPubMed Raszeja V, Jordens C, Kerridge I (2013) Survey of practices and polices relating to the use of complementary and alternatives medicines and therapies in New South Wales cancer services. Intern Med J 43:84–88CrossRefPubMed
9.
Zurück zum Zitat Lim EJ, Dhillon HM, Oh BS, Vardy JL (2015) Have Australian cancer hospitals integrated complementary and alternative medicine and supportive care programs into clinical services? Adv Integr Med 2(2):116CrossRef Lim EJ, Dhillon HM, Oh BS, Vardy JL (2015) Have Australian cancer hospitals integrated complementary and alternative medicine and supportive care programs into clinical services? Adv Integr Med 2(2):116CrossRef
10.
Zurück zum Zitat NCCAM (2001) Can alternative medicine be integrated into mainstream care. UK, London NCCAM (2001) Can alternative medicine be integrated into mainstream care. UK, London
11.
Zurück zum Zitat Cohen MH, Hrbek A, Davis RB, Schachter SC, Kemper KJ, Boyer EW et al (2005) Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med 165(3):289–296CrossRefPubMed Cohen MH, Hrbek A, Davis RB, Schachter SC, Kemper KJ, Boyer EW et al (2005) Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med 165(3):289–296CrossRefPubMed
12.
Zurück zum Zitat Grant S, Bensoussan A (2014) The process of care in integrative health care settings—a qualitative study of US practices. BMC Complement Altern Med 14(1):410CrossRefPubMedPubMedCentral Grant S, Bensoussan A (2014) The process of care in integrative health care settings—a qualitative study of US practices. BMC Complement Altern Med 14(1):410CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Rossi E, Vita A, Baccetti S, Stefano M, Voller F, Zanobini A (2014) Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 23(6):1795–1806CrossRefPubMed Rossi E, Vita A, Baccetti S, Stefano M, Voller F, Zanobini A (2014) Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 23(6):1795–1806CrossRefPubMed
15.
Zurück zum Zitat Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, et al. (2017). Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, et al. (2017). Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians
16.
Zurück zum Zitat Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL et al (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85–120PubMed Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL et al (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85–120PubMed
18.
Zurück zum Zitat Furzer BJ, Petterson AS, Wright KE, Wallman KE, Ackland TR, Joske DJ (2014) Positive patient experiences in an Australian integrative oncology centre. BMC Complement Altern Med 14:158CrossRefPubMedPubMedCentral Furzer BJ, Petterson AS, Wright KE, Wallman KE, Ackland TR, Joske DJ (2014) Positive patient experiences in an Australian integrative oncology centre. BMC Complement Altern Med 14:158CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Furzer BJ, Wright KE, Petterson AS, Wallman KE, Ackland TR, Joske DJ (2013) Characteristics and quality of life of patients presenting to cancer support centres: patient rated outcomes and use of complementary therapies. BMC Complement Altern Med 13(1):169CrossRefPubMedPubMedCentral Furzer BJ, Wright KE, Petterson AS, Wallman KE, Ackland TR, Joske DJ (2013) Characteristics and quality of life of patients presenting to cancer support centres: patient rated outcomes and use of complementary therapies. BMC Complement Altern Med 13(1):169CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Olver I, Robotin M (2012) Perspectives on complementary and alternative medicines. Imperial College Press, London Olver I, Robotin M (2012) Perspectives on complementary and alternative medicines. Imperial College Press, London
21.
Zurück zum Zitat CATAG (2013) Rethinking medicines decision-making in Australian hospitals: guiding principles for the quality use of off-label medicines. Council of Australian Therapeutic Advisory Groups, Australia CATAG (2013) Rethinking medicines decision-making in Australian hospitals: guiding principles for the quality use of off-label medicines. Council of Australian Therapeutic Advisory Groups, Australia
22.
Zurück zum Zitat Braun L, Harris J, Katris P, Cain M, Dhillon H, Koczwara B et al (2014) Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia-Pacific J Clin Oncol 10(4):289–296CrossRef Braun L, Harris J, Katris P, Cain M, Dhillon H, Koczwara B et al (2014) Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia-Pacific J Clin Oncol 10(4):289–296CrossRef
23.
Zurück zum Zitat Scott C (2012) The Dr Dorothea Sandars and Irene Lee Churchill Fellowship to study the integration of complementary and supportive therapies with conventional medical care for people with cancer—USA, UK Scott C (2012) The Dr Dorothea Sandars and Irene Lee Churchill Fellowship to study the integration of complementary and supportive therapies with conventional medical care for people with cancer—USA, UK
24.
Zurück zum Zitat Kerridge IH, McPhee JR (2004) Ethical and legal issues at the interface of complementary and conventional medicine. Med J Aust 181(3):164–166PubMed Kerridge IH, McPhee JR (2004) Ethical and legal issues at the interface of complementary and conventional medicine. Med J Aust 181(3):164–166PubMed
25.
Zurück zum Zitat Weir M (2011) Law and ethics in complementary medicine: a handbook for practitioners in Australia and New Zealand. Allen and Unwin, Australia Weir M (2011) Law and ethics in complementary medicine: a handbook for practitioners in Australia and New Zealand. Allen and Unwin, Australia
26.
Zurück zum Zitat Robotin MC, Penman AG (2006) Integrating complementary therapies into mainstream cancer care: which way forward? Med J Aust 185(7):377–379PubMed Robotin MC, Penman AG (2006) Integrating complementary therapies into mainstream cancer care: which way forward? Med J Aust 185(7):377–379PubMed
27.
Zurück zum Zitat Hunter J, Corcoran K, Phelps K, Leeder S (2012) The challenges of establishing an integrative medicine primary care clinic in Sydney. Australia J Altern Complement Med 18(11):1008–1013CrossRefPubMed Hunter J, Corcoran K, Phelps K, Leeder S (2012) The challenges of establishing an integrative medicine primary care clinic in Sydney. Australia J Altern Complement Med 18(11):1008–1013CrossRefPubMed
28.
Zurück zum Zitat Hunter J, Corcoran K, Phelps K, Leeder S (2012) The integrative medicine team—is biomedical dominance inevitable? J Altern Complement Med 18(12):1127–1132CrossRefPubMed Hunter J, Corcoran K, Phelps K, Leeder S (2012) The integrative medicine team—is biomedical dominance inevitable? J Altern Complement Med 18(12):1127–1132CrossRefPubMed
29.
Zurück zum Zitat Bodeker G (2012) Integrative oncology meets immunotherapy: new prospects for combination therapy grounded in Eastern medical knowledge. Chin J Integr Med 18(9):652–662CrossRefPubMed Bodeker G (2012) Integrative oncology meets immunotherapy: new prospects for combination therapy grounded in Eastern medical knowledge. Chin J Integr Med 18(9):652–662CrossRefPubMed
30.
Zurück zum Zitat Donabedian A (1992) Quality assurance. Structure, process and outcome. Nurs Stand 7(11 Suppl QA):4–5PubMed Donabedian A (1992) Quality assurance. Structure, process and outcome. Nurs Stand 7(11 Suppl QA):4–5PubMed
31.
Zurück zum Zitat Rademakers J, Delnoij D, de Boer D (2011) Structure, process or outcome: which contributes most to patients’ overall assessment of healthcare quality? BMJ Quality Safety 20(4):326–331CrossRefPubMed Rademakers J, Delnoij D, de Boer D (2011) Structure, process or outcome: which contributes most to patients’ overall assessment of healthcare quality? BMJ Quality Safety 20(4):326–331CrossRefPubMed
32.
Zurück zum Zitat Mittring N, Perard M, Witt CM (2013) Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers. Evid Based Complement Alternat Med 2013:8CrossRef Mittring N, Perard M, Witt CM (2013) Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers. Evid Based Complement Alternat Med 2013:8CrossRef
33.
Zurück zum Zitat Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ (2007) Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):340s–354sCrossRefPubMed Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ (2007) Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):340s–354sCrossRefPubMed
34.
Zurück zum Zitat WHO (2003) WHO guidelines. World Health Organisation, Geneva WHO (2003) WHO guidelines. World Health Organisation, Geneva
35.
Zurück zum Zitat Kastner M, Tricco A, Soobiah C, Lillie E, Perrier L, Horsley T et al (2012) What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review. BMC Med Res Methodol 12:114CrossRefPubMedPubMedCentral Kastner M, Tricco A, Soobiah C, Lillie E, Perrier L, Horsley T et al (2012) What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review. BMC Med Res Methodol 12:114CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat MacKenzie-Cook PD (2006) Challenging the new orthodoxy in integrative medicine. J Altern Complement Med 12(7):679–683CrossRefPubMed MacKenzie-Cook PD (2006) Challenging the new orthodoxy in integrative medicine. J Altern Complement Med 12(7):679–683CrossRefPubMed
37.
Zurück zum Zitat Wardle J, Weir M, Marshall B, Archer E (2014) Regulatory and legislative protections for consumers in complementary medicine: lessons from Australian policy and legal developments. Eur J Integr Med 6(4):423–433CrossRef Wardle J, Weir M, Marshall B, Archer E (2014) Regulatory and legislative protections for consumers in complementary medicine: lessons from Australian policy and legal developments. Eur J Integr Med 6(4):423–433CrossRef
39.
Zurück zum Zitat Kligler B, Homel P, Harrison LB, Levenson HD, Kenney JB, Merrell W (2011) Cost savings in inpatient oncology through an integrative medicine approach. Am J Manag Care 17(12):779–784PubMed Kligler B, Homel P, Harrison LB, Levenson HD, Kenney JB, Merrell W (2011) Cost savings in inpatient oncology through an integrative medicine approach. Am J Manag Care 17(12):779–784PubMed
40.
Zurück zum Zitat Johnson JR, Crespin DJ, Griffin KH, Finch MD, Dusek JA (2014) Effects of integrative medicine on pain and anxiety among oncology inpatients. J Natl Cancer Inst Monogr 50(330):e337 Johnson JR, Crespin DJ, Griffin KH, Finch MD, Dusek JA (2014) Effects of integrative medicine on pain and anxiety among oncology inpatients. J Natl Cancer Inst Monogr 50(330):e337
41.
Zurück zum Zitat Robotin M, Holliday C, Bensoussan A (2012) Defining research priorities in complementary medicine in oncology. Complement Ther Med 20(5):345–352CrossRefPubMed Robotin M, Holliday C, Bensoussan A (2012) Defining research priorities in complementary medicine in oncology. Complement Ther Med 20(5):345–352CrossRefPubMed
42.
Zurück zum Zitat Sagar SM (2008) How do we evaluate outcome in an integrative oncology program? Curr Oncol (Toronto, Ont) 15(Suppl 2):s78–s82 Sagar SM (2008) How do we evaluate outcome in an integrative oncology program? Curr Oncol (Toronto, Ont) 15(Suppl 2):s78–s82
43.
Zurück zum Zitat Vohra S, Cvijovic K, Boon H, Foster BC, Jaeger W, LeGatt D et al (2012) Study of Natural Health Product Adverse Reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS One 7(9):e45196CrossRefPubMedPubMedCentral Vohra S, Cvijovic K, Boon H, Foster BC, Jaeger W, LeGatt D et al (2012) Study of Natural Health Product Adverse Reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS One 7(9):e45196CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Haroon M, Ranmal R, McElroy H, Dudley J (2015) Developing clinical guidelines: how much rigour is required? Arch Dis Child Educ Pract Ed 100(2):89–96 Haroon M, Ranmal R, McElroy H, Dudley J (2015) Developing clinical guidelines: how much rigour is required? Arch Dis Child Educ Pract Ed 100(2):89–96
45.
Zurück zum Zitat Frenkel M, Cohen L, Peterson N, Palmer J, Swint K, Bruera E (2010) Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther 9(3):276–283CrossRefPubMed Frenkel M, Cohen L, Peterson N, Palmer J, Swint K, Bruera E (2010) Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther 9(3):276–283CrossRefPubMed
46.
Zurück zum Zitat Hunter J, Corcoran K, Leeder S, Phelps K (2013) Integrative medicine outcomes: what should we measure? Complement Ther Clin Pract 19(1):20–26CrossRefPubMed Hunter J, Corcoran K, Leeder S, Phelps K (2013) Integrative medicine outcomes: what should we measure? Complement Ther Clin Pract 19(1):20–26CrossRefPubMed
47.
Zurück zum Zitat Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM (2015) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557–565 Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM (2015) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557–565
48.
Zurück zum Zitat Grant SJ, Frawley J, Bensoussan A (2015) Process of care in outpatient integrative healthcare facilities: a systematic review of clinical trials. BMC Health Serv Res 15(1):1CrossRef Grant SJ, Frawley J, Bensoussan A (2015) Process of care in outpatient integrative healthcare facilities: a systematic review of clinical trials. BMC Health Serv Res 15(1):1CrossRef
49.
Zurück zum Zitat Witt CM, Ausserer O, Baier S, Heidegger H, Icke K, Mayr O et al (2015) Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial. Breast Cancer Res Treat 149(2):449–460CrossRefPubMed Witt CM, Ausserer O, Baier S, Heidegger H, Icke K, Mayr O et al (2015) Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial. Breast Cancer Res Treat 149(2):449–460CrossRefPubMed
50.
Zurück zum Zitat Coulter ID, Herman PM, Nataraj S (2013) Economic analysis of complementary, alternative, and integrative medicine: considerations raised by an expert panel. BMC Complement Altern Med 13(1):1–9CrossRef Coulter ID, Herman PM, Nataraj S (2013) Economic analysis of complementary, alternative, and integrative medicine: considerations raised by an expert panel. BMC Complement Altern Med 13(1):1–9CrossRef
51.
Zurück zum Zitat Deng G, Weber W, Sood A, Kemper KJ (2010) Research on integrative healthcare: context and priorities. EXPLORE: J Sci Healing 6(3):143–158CrossRef Deng G, Weber W, Sood A, Kemper KJ (2010) Research on integrative healthcare: context and priorities. EXPLORE: J Sci Healing 6(3):143–158CrossRef
52.
Zurück zum Zitat Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai J-S et al (2007) Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25(32):5106–5112CrossRefPubMed Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai J-S et al (2007) Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25(32):5106–5112CrossRefPubMed
53.
Zurück zum Zitat Hibbard JH, Stockard J, Mahoney ER, Tusler M (2004) Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39(4 Pt 1):1005–1026CrossRefPubMedPubMedCentral Hibbard JH, Stockard J, Mahoney ER, Tusler M (2004) Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39(4 Pt 1):1005–1026CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Hibbard JH, Greene J, Overton V (2013) Patients with lower activation associated with higher costs; delivery systems should know their patients’ scores. Health Aff 32(2):216–222CrossRef Hibbard JH, Greene J, Overton V (2013) Patients with lower activation associated with higher costs; delivery systems should know their patients’ scores. Health Aff 32(2):216–222CrossRef
55.
Zurück zum Zitat Polley M, Frenkel M, Balneaves L, Zollman C, Seely D, Abrams D, et al. Developing guidelines for the collection of patient outcomes data in clinical integrative oncology settings. Abstract 60. Presented November 15, 2015. SIO 12th International Conference; 15 November; Boston, USA2015 Polley M, Frenkel M, Balneaves L, Zollman C, Seely D, Abrams D, et al. Developing guidelines for the collection of patient outcomes data in clinical integrative oncology settings. Abstract 60. Presented November 15, 2015. SIO 12th International Conference; 15 November; Boston, USA2015
56.
Zurück zum Zitat Girgs A, Delaney G, Miller A (2015) Utilising eHealth to support survivorship care. Cancer Forum 39(2):86–89 Girgs A, Delaney G, Miller A (2015) Utilising eHealth to support survivorship care. Cancer Forum 39(2):86–89
57.
Zurück zum Zitat Lim E, Vardy JL, Oh B, Dhillon HM (2017) Integration of complementary and alternative medicine into cancer-specific supportive care programs in Australia: a scoping study. Asia Pac J Clin Oncol 13(1):6–12 Lim E, Vardy JL, Oh B, Dhillon HM (2017) Integration of complementary and alternative medicine into cancer-specific supportive care programs in Australia: a scoping study. Asia Pac J Clin Oncol 13(1):6–12
58.
Zurück zum Zitat Grant SJ, Bensoussan A (2014) The process of care in integrative health care settings—a qualitative study of US practices. BMC Complement Altern Med 14(1):1CrossRef Grant SJ, Bensoussan A (2014) The process of care in integrative health care settings—a qualitative study of US practices. BMC Complement Altern Med 14(1):1CrossRef
59.
Zurück zum Zitat Hunter J, Leeder S (2013) Patient questionnaires for use in the integrative medicine primary care setting—a systematic literature review. Eur J Integr Med 5(3):194–216CrossRef Hunter J, Leeder S (2013) Patient questionnaires for use in the integrative medicine primary care setting—a systematic literature review. Eur J Integr Med 5(3):194–216CrossRef
60.
Zurück zum Zitat Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88(9):2164–2171CrossRefPubMed Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88(9):2164–2171CrossRefPubMed
61.
Zurück zum Zitat Jolliffe R, Seers H, Jackson S, Caro E, Weeks L, Polley MJ (2015) The responsiveness, content validity, and convergent validity of the Measure Yourself Concerns and Wellbeing (MYCaW) patient-reported outcome measure. Integr Cancer Ther 14(1):26–34CrossRefPubMed Jolliffe R, Seers H, Jackson S, Caro E, Weeks L, Polley MJ (2015) The responsiveness, content validity, and convergent validity of the Measure Yourself Concerns and Wellbeing (MYCaW) patient-reported outcome measure. Integr Cancer Ther 14(1):26–34CrossRefPubMed
62.
Zurück zum Zitat Cella D, Choi S, Garcia S, Cook KF, Rosenbloom S, Lai J-S et al (2014) Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Qual Life Res 23(10):2651–2661CrossRefPubMedPubMedCentral Cella D, Choi S, Garcia S, Cook KF, Rosenbloom S, Lai J-S et al (2014) Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Qual Life Res 23(10):2651–2661CrossRefPubMedPubMedCentral
Metadaten
Titel
Guidance for establishing an integrative oncology service in the Australian healthcare setting—a discussion paper
verfasst von
Suzanne J. Grant
Jennifer Hunter
Alan Bensoussan
Geoff P. Delaney
Publikationsdatum
01.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3851-0

Weitere Artikel der Ausgabe 2/2018

Supportive Care in Cancer 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.